Atlas Trials

An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Clinical trial NCT00250601 · COMPLETED

Trial details

NCT number
NCT00250601
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Depressive Disorder
Start date
2005-04-01
Primary completion
2007-07-01
Enrollment
460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.